iExosomes in Treating Participants With Metastatic Pancreas Cancer With KrasG12D Mutation

Clinical trial NCT03608631 · RECRUITING

Trial details

NCT number: NCT03608631
Sponsor: M.D. Anderson Cancer Center
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

KRAS NP_004976.2:p.G12D Metastatic Pancreatic Adenocarcinoma Pancreatic Ductal Adenocarcinoma Stage IV Pancreatic Cancer AJCC v8

Start date: 2021-01-27
Primary completion: 2027-04-30
Enrollment: 28

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.